Works matching DE "CLOPIDOGREL"

Results: 2245
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel: Influence of alternate-day dosing of vonoprazan.

    Published in:
    European Journal of Clinical Pharmacology, 2022, v. 78, n. 6, p. 955, doi. 10.1007/s00228-022-03313-2
    By:
    • Higuchi, Tomohiro;
    • Yamade, Mihoko;
    • Takahashi, Satoru;
    • Tamura, Satoshi;
    • Tani, Shinya;
    • Kagami, Takuma;
    • Uotani, Takahiro;
    • Hamaya, Yasushi;
    • Iwaizumi, Moriya;
    • Osawa, Satoshi;
    • Sugimoto, Ken;
    • Furuta, Takahisa
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Half-dose ticagrelor versus high-dose clopidogrel in reducing platelet reactivity in acute coronary syndrome patients with high on-clopidogrel platelet reactivity (divide study).

    Published in:
    European Journal of Clinical Pharmacology, 2019, v. 75, n. 8, p. 1059, doi. 10.1007/s00228-019-02687-0
    By:
    • Liu, Guang Zhong;
    • Zhang, Song;
    • Sun, Dang Hui;
    • Shi, Jing;
    • Bo, Wan Lan;
    • Wang, Wen Nan;
    • Zhang, Chong Yang;
    • Wang, Zhong Hua;
    • Feng, Wei;
    • He, Mei Jiao;
    • Liu, Yuan Yuan;
    • Li, Shuang;
    • Zheng, Lin Qun;
    • Li, Yue
    Publication type:
    Article
    27
    28

    Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?

    Published in:
    European Journal of Clinical Pharmacology, 2018, v. 74, n. 12, p. 1567, doi. 10.1007/s00228-018-2530-5
    By:
    • Chouchene, Saoussen;
    • Dabboubi, Rym;
    • Raddaoui, Haythem;
    • Abroug, Hela;
    • Ben Hamda, Khaldoun;
    • Hadj Fredj, Sondess;
    • Abderrazak, Fatma;
    • Gaaloul, Mayssa;
    • Rezek, Marwa;
    • Neffeti, Fadoua;
    • Hellara, Ilhem;
    • Sassi, Mouna;
    • Khefacha, Linda;
    • Sriha, Asma;
    • Nouira, Semir;
    • Najjar, Mohamed Fadhel;
    • Maatouk, Faouzi;
    • Messaoud, Taieb;
    • Hassine, Mohsen
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study.

    Published in:
    European Journal of Clinical Pharmacology, 2015, v. 71, n. 11, p. 1315, doi. 10.1007/s00228-015-1917-9
    By:
    • Collet, Jean-Philippe;
    • Hulot, Jean-Sébastien;
    • Cuisset, Thomas;
    • Rangé, Grégoire;
    • Cayla, Guillaume;
    • Belle, Eric;
    • Elhadad, Simon;
    • Rousseau, Hélène;
    • Sabouret, Pierre;
    • O'Connor, Stephen;
    • Abtan, Jérémie;
    • Kerneis, Mathieu;
    • Saint-Etienne, Christophe;
    • Barthélémy, Olivier;
    • Beygui, Farzin;
    • Silvain, Johanne;
    • Vicaut, Eric;
    • Montalescot, Gilles
    Publication type:
    Article
    41
    42
    43

    Prasugrel but not high dose clopidogrel overcomes the lansoprazole neutralizing effect of P2Y inhibition: Results of the randomized DOSAPI study.

    Published in:
    European Journal of Clinical Pharmacology, 2014, v. 70, n. 9, p. 1049, doi. 10.1007/s00228-014-1710-1
    By:
    • Collet, Jean-Philippe;
    • Hulot, Jean-Sébastien;
    • Abtan, Jérémie;
    • Anzaha, Ghalia;
    • Kerneis, Mathieu;
    • Silvain, Johanne;
    • Cayla, Guillaume;
    • O'Connor, Stephen;
    • Barthélémy, Olivier;
    • Beygui, Farzin;
    • Galier, Sophie;
    • Brugier, Delphine;
    • Stanek, Eric;
    • Charland, Scott;
    • Gallois, Vanessa;
    • Montalescot, Gilles
    Publication type:
    Article
    44

    Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.

    Published in:
    European Journal of Clinical Pharmacology, 2014, v. 70, n. 6, p. 667, doi. 10.1007/s00228-014-1672-3
    By:
    • Hokimoto, Seiji;
    • Chitose, Tadasuke;
    • Mizobe, Michio;
    • Akasaka, Tomonori;
    • Arima, Yuichiro;
    • Kaikita, Koichi;
    • Iwashita, Satomi;
    • Morita, Kazunori;
    • Miyazaki, Hiroko;
    • Oniki, Kentaro;
    • Matsui, Kunihiko;
    • Nakagawa, Kazuko;
    • Ogawa, Hisao
    Publication type:
    Article
    45
    46

    Effect of the CYP2C19*2 and *3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention.

    Published in:
    European Journal of Clinical Pharmacology, 2013, v. 69, n. 5, p. 1103, doi. 10.1007/s00228-012-1446-8
    By:
    • Tang, Xiao-Fang;
    • Wang, Jing;
    • Zhang, Jia-Hui;
    • Meng, Xian-Min;
    • Xu, Bo;
    • Qiao, Shu-Bin;
    • Wu, Yong-Jian;
    • Chen, Jue;
    • Wu, Yuan;
    • Chen, Ji-Lin;
    • Gao, Run-Lin;
    • Yuan, Jin-Qing;
    • Yang, Yue-Jin
    Publication type:
    Article
    47
    48
    49
    50